title: DEPTOR expression and response to thalidomide: toward a new therapeutic target in multiple myeloma?
authors.affiliation: Hematology Service, Hospital La Fe, Valencia, Spain. delarubia_jav@gva.es
authors.forename: Javier
authors.initials: J
authors.lastname: de la Rubia
authors.forename: Esperanza
authors.initials: E
authors.lastname: Such
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D054316:Biomarkers, Pharmacological / Q000032:analysis / Q000378:metabolism; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D058990:Molecular Targeted Therapy / Q000639:trends*; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000235:genetics; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D013792:Thalidomide / Q000627:therapeutic use*
chemical_list: D020533:Angiogenesis Inhibitors; D054316:Biomarkers, Pharmacological; D047908:Intracellular Signaling Peptides and Proteins; D013792:Thalidomide; C556139:DEPTOR protein, human; D058570:TOR Serine-Threonine Kinases